By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Valeritas 



Ramsey  New Jersey    U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Valeritas’ V-Go Wearable Insulin Delivery Device Provides Clinical And Economic Benefits, A1C Response And Lower Total Daily Insulin Dose Through Prospective Randomized Trial And Real-World Use By Patients With Type 2 Diabetes 6/12/2017 11:53:10 AM
Valeritas Appoints Peter J. Devlin To Chairman Of Its Board Of Directors 6/7/2017 10:45:27 AM
Valeritas’ V-Go Wearable Insulin Delivery Device Results In Significant Reductions In A1C, Insulin Requirements And Cost Reductions In Patients With Diabetes 5/22/2017 9:38:44 AM
Valeritas Reports First Quarter 2017 Financial Results 5/12/2017 8:28:57 AM
Valeritas’ V-Go Wearable Insulin Delivery Device Provided Significant And Sustained A1C Reductions And Achieved A1C Glycemic Targets In Patients With Type 2 Diabetes 5/5/2017 11:22:02 AM
Valeritas’ V-Go Wearable Insulin Delivery Device Provided Significant And Sustained A1C Reductions And Achieved A1C Glycemic Targets In Patients With Type 2 Diabetes 5/5/2017 9:53:41 AM
Valeritas To Host Conference Call With Clinical Experts To Discuss Their Treatment Of Patients With Type 2 Diabetes And V-Go® On May 18, 2017 5/3/2017 8:59:47 AM
Valeritas Announces Presentations For Upcoming Medical Conferences: American Association of Clinical Endocrinologists, International Society For Pharmacoepidemiology And American Diabetes Association 5/1/2017 9:45:33 AM
Valeritas To Release First Quarter 2017 Financial Results And Host Conference Call On Friday, May 12, 2017 4/27/2017 9:39:28 AM
Article Published In Managed Care Highlights The Benefits Of Diabetes Medication Delivery Devices, Including Valeritas’ V-Go Device 4/6/2017 12:01:24 PM
12345
//-->